Transfemoral Tricuspid Valve-in-Ring Implantation Using the Edwards Sapien XT Valve
2015; Lippincott Williams & Wilkins; Volume: 8; Issue: 3 Linguagem: Inglês
10.1161/circinterventions.114.002225
ISSN1941-7632
AutoresClaire Bouleti, Dominique Himbert, Éric Brochet, Phalla Ou, Bernard Iung, Mohammed Nejjari, Walid Ghodbane, Amir-Ali Fassa, Jean‐Pol Depoix, Alec Vahanian,
Tópico(s)Cardiac Structural Anomalies and Repair
ResumoHomeCirculation: Cardiovascular InterventionsVol. 8, No. 3Transfemoral Tricuspid Valve-in-Ring Implantation Using the Edwards Sapien XT Valve Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissionsDownload Articles + Supplements ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toSupplemental MaterialFree AccessResearch ArticlePDF/EPUBTransfemoral Tricuspid Valve-in-Ring Implantation Using the Edwards Sapien XT ValveOne-Year Follow-Up Claire Bouleti, MD, PhD, Dominique Himbert, MD, Eric Brochet, MD, Phalla Ou, MD, PhD, Bernard Iung, MD, Mohammed Nejjari, MD, Walid Ghodbane, MD, Amir-Ali Fassa, MD, Jean-Pol Depoix, MD and Alec Vahanian, MD Claire BouletiClaire Bouleti From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. , Dominique HimbertDominique Himbert From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. , Eric BrochetEric Brochet From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. , Phalla OuPhalla Ou From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. , Bernard IungBernard Iung From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. , Mohammed NejjariMohammed Nejjari From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. , Walid GhodbaneWalid Ghodbane From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. , Amir-Ali FassaAmir-Ali Fassa From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. , Jean-Pol DepoixJean-Pol Depoix From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. and Alec VahanianAlec Vahanian From the Departments of Cardiology (C.B., D.H., E.B., B.I., M.N., A.-A.F., A.V.), Cardiovascular Surgery (W.G.), Anesthesiology (J.-P.D.), and Radiology (P.O.), Bichat-Claude-Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Paris, France. Originally published5 Mar 2015https://doi.org/10.1161/CIRCINTERVENTIONS.114.002225Circulation: Cardiovascular Interventions. 2015;8:e002225Between November 2012 and August 2013, after multidisciplinary evaluation, 3 high-risk patients underwent transfemoral tricuspid valve-in-ring implantation (TVIRI) for refractory congestive heart failure because of deterioration of their tricuspid surgery, using Sapien XT valves (Edwards Lifesciences Inc, Irvine, CA).Patient 1: 44-year-old man, drug abuse, 4 episodes of tricuspid endocarditis, 2 previous cardiac surgeries for mitral homograft in tricuspid position with 30-mm Classic Carpentier Edwards annuloplasty ring (2001), presenting with massive central tricuspid regurgitation (TR; Figure 1A).Download figureDownload PowerPointFigure 1. Color transesophageal echocardiography (TEE) image of tricuspid regurgitation (TR) before implantation on the left panels. A, Patient 1: severe TR with 2 jets, one emanating from the center of the homograft and the second from the medial part of the prosthetic annulus. B, Patient 2: severe central intraprosthetic jet. C, Patient 3: severe central intraprosthetic jet. Color TEE image of TR after valve-in-ring implantation on the right panels: A′, Patient 1: mild residual TR with an excentric jet coming from the medial part of the prosthetic annulus. Mid-esophageal two-dimensional (2D) TEE view at 0°, compare black and white and color Doppler. B′, Patient 2: trace TR coming from the medial part of the prosthetic annulus. Mid-esophageal 2D TEE view at 90°, compare black and white and color Doppler. C′, Patient 3: moderate-to-severe residual paravalvular TR with a jet coming from the medial part of the prosthetic annulus. Mid-esophageal Xplane 2D TEE view with color Doppler (left corresponds to 0°, right to 90°). RA indicates right atrium; and RV, right ventricle.Patient 2: 69-year-old man, tricuspid endocarditis treated by valve replacement with 30-mm bioprosthesis (1982), mitral homograft in tricuspid position with 30-mm Carpentier Edwards annuloplasty ring and coronary artery bypass grafting (1998), presenting severe homograft degeneration with stenosis and severe central TR (Figure 1B).Patients 3: 58-year-old woman, rheumatic heart disease, mitral valve repair, and tricuspid annuloplasty with a 32-mm rigid Carpentier Edwards annuloplasty ring (1988), mechanical mitral valve replacement (1999), with severe central TR (Figure 1C).The choice of the Sapien XT valve size was based on ring diameters determined by computed tomography, three-dimensional (3D) transesophageal echocardiography and fluoroscopy, with the aim of implanting a valve whose diameter was closest to the mean inner diameter of the ring (Figure 2). However, considering that 23-mm Sapien XT valves would lead to high transprothetic gradients, only 26- and 29-mm valves were considered.Download figureDownload PowerPointFigure 2. Measurement of the inner diameter of an annuloplasty ring by fluoroscopy, showing the long and short axis (black lines) taken into account to measure the mean inner diameter (A), computed tomography (B), and three-dimensional transesophageal echocardiography (TEE; C). Mean inner diameter measurements using the 3 methods (D). CT indicates computed tomography.All procedures were performed via the transvenous femoral approach, under general anesthesia and transesophageal echocardiography guidance. The tricuspid valve was crossed with a Judkins right or a balloon floating catheter placed through a Mullins sheath. A J-preshaped 0.035 Amplatz SuperStiff wire was placed at the apex of the right ventricle. Then, the Sapien XT valve, mounted on a Novaflex catheter in an antegrade position, was deployed by slow balloon inflation under rapid ventricular pacing. Rapid ventricular pacing was performed using a permanent pacemaker via the epicardium (patient 1) or the coronary sinus (patients 2 and 3). In all patients, a 26-mm Sapien XT valve was successfully implanted. After the final results had been evaluated in the catheterization laboratory by echocardiography and fluoroscopy, patients underwent a computed tomographic scan before discharge using computed 3D reconstruction (Figure 3).Download figureDownload PowerPointFigure 3. Computed tomographic (CT) images of patient 3 ring before (A) and after (B and C) the Sapien XT valve implantation. Inner rings' diameters using CT scan measurements (D).On predischarge echocardiographic examination, mean transvalvular gradients ranged from 3 to 5 mm Hg and paravalvular TR around the Sapien valve was mild in patient 1, absent in patient 2, and moderate-to-severe in patient 3 (Figure 1A′–C′; Movies I–IV in the Data Supplement). At 30-day follow-up, there was no complication and all patients had a significant improvement in their functional status (New York Heart Association classes I or II). At 1-year follow-up, they were alive with no change in their functional status. The tricuspid gradients remained stable.DiscussionAlthough the feasibility of transcatheter valve-in-ring implantation in mitral position has been demonstrated,1,2 only 2 case reports on the immediate results of TVIRI have been published,3,4 using the transatrial and the transfemoral approaches, and the latter concerned a patient presented in this series (patient 1).One important difficulty is the proper evaluation of the prosthesis size, because Carpentier Edwards Classic tricuspid rings are oval, open, and surrounded by valvular tissue, which cannot be detected by computed tomographic scanner or fluoroscopy. In this series, 2 patients (1 and 3) had a residual paravalvular leak at the level of the open portion of the ring, probably because of the oval shape and the inability to completely seal the open segment with the transcatheter heart valve. Balloon sizing might have been performed and led to implantation of a 29-mm Sapien XT valve, with less degree of paravalvular TR. However, the difficulty of changing the rings' geometry is illustrated by Figure 3 showing computed tomographic acquisitions before and after balloon-expandable valve implantation, along with the diameters (Figure 3).Thus, TVIRI with the current generation of Sapien XT valves should be considered with caution. In the presence of severe residual paravalvular TR, its immediate correction should be technically feasible and might be considered. In the future, more conformable or repositionable valves, with additional sealing capacity may help to reduce regurgitation after TVIRI.The transfemoral approach has the advantage of being less invasive than a transatrial approach and the avoidance of a thoracotomy was desirable given the high-risk profile of our patients.Rapid ventricular pacing had to take into account the potential damage to the lead of a permanent pacemaker across the ring and also avoid jailing a temporary pacing lead. In 2 patients who had permanent pacemaker, we chose to implant another lead in the coronary sinus. The third patient had a permanent epicardial pacemaker placed before the procedure because of sinus dysfunction.This small series suggests that transfemoral TVIRI after failure of tricuspid surgery is feasible and may improve hemodynamic and functional status in highly selected patients, both immediately and at 1-year follow-up. Larger series with longer follow-up are needed to assess the potential role of this technique and will certainly be useful for future tricuspid transcatheter valve therapies with dedicated devices.DisclosuresDr Himbert is a consultant and a proctor for Edwards Lifesciences. Drs Iung and Vahanian received speaker's fees from Edwards Lifesciences. The other authors report no conflicts.FootnotesThe Data Supplement is available at http://circinterventions.ahajournals.org/lookup/suppl/doi:10.1161/CIRCINTERVENTIONS.114.002225/-/DC1.Correspondence to Dominique Himbert, MD, Department of Cardiology, Bichat Hospital, 46 rue Henri-Huchard, 75018 Paris, France. E-mail [email protected]References1. Kondo N, Shuto T, McGarvey JR, Koomalsingh KJ, Takebe M, Gorman RC, Gorman JH, Gillespie MJ.Melody valve-in-ring procedure for mitral valve replacement: feasibility in four annuloplasty types.Ann Thorac Surg. 2012; 93:783–788. doi: 10.1016/j.athoracsur.2011.12.021.CrossrefMedlineGoogle Scholar2. Bouleti C, Fassa AA, Himbert D, Brochet E, Ducrocq G, Nejjari M, Ghodbane W, Depoix JP, Nataf P, Vahanian A.Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or surgical repair.JACC Cardiovasc Interv. 2015; 8(1 pt A):83–91. doi: 10.1016/j.jcin.2014.07.026.CrossrefMedlineGoogle Scholar3. Mazzitelli D, Bleiziffer S, Noebauer C, Ruge H, Mayr P, Opitz A, Tassani-Prell P, Schreiber C, Piazza N, Lange R.Transatrial antegrade approach for double mitral and tricuspid "valve-in-ring" implantation.Ann Thorac Surg. 2013; 95:e25–e27. doi: 10.1016/j.athoracsur.2012.09.092.CrossrefMedlineGoogle Scholar4. Fassa AA, Himbert D, Brochet E, Labbé JP, Vahanian A.Transfemoral valve-in-ring implantation for a failing mitral homograft in the tricuspid position.EuroIntervention. 2014; 10:269. doi: 10.4244/EIJV10I2A43.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Russo G, Taramasso M, Pedicino D, Gennari M, Gavazzoni M, Pozzoli A, Muraru D, Badano L, Metra M and Maisano F (2021) Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities?, European Journal of Heart Failure, 10.1002/ejhf.2398, 24:3, (442-454), Online publication date: 1-Mar-2022. Praz F, Muraru D, Kreidel F, Lurz P, Hahn R, Delgado V, Senni M, von Bardeleben R, Nickenig G, Hausleiter J, Mangieri A, Zamorano J, Prendergast B and Maisano F (2021) Transcatheter treatment for tricuspid valve disease, EuroIntervention, 10.4244/EIJ-D-21-00695, 17:10, (791-808), Online publication date: 1-Nov-2021. Capretti G, Urena M, Bouleti C and Himbert D (2019) Transcatheter tricuspid valve‐in‐valve replacement: Making it simpler, Catheterization and Cardiovascular Interventions, 10.1002/ccd.28170, 95:1, (65-67), Online publication date: 1-Jan-2020. Melillo F, Ferri L, Beneduce A, Baldetti L, Ancona M, Bellini B, Chieffo A, Palmisano A, Esposito A, Agricola E and Montorfano M (2020) Percutaneous Transjugular Tricuspid Valve-In-Valve Implantation for Degenerated Surgical Bioprosthetic Valve, Cardiovascular Revascularization Medicine, 10.1016/j.carrev.2019.11.012, 21:6, (808-809), Online publication date: 1-Jun-2020. Ghobrial J, Reemtsen B, Levi D and Aboulhosn J (2018) Trans‐apical systemic tricuspid valve‐in‐ring replacement, Catheterization and Cardiovascular Interventions, 10.1002/ccd.28049, 93:6, (1165-1169), Online publication date: 1-May-2019. Noble S, Myers P, Hachulla A and Huber C (2019) Unsuccessful Transfemoral Tricuspid Valve-in-Ring Implantation: Case Report and Literature Review, CJC Open, 10.1016/j.cjco.2019.09.005, 1:6, (330-334), Online publication date: 1-Nov-2019. Abdelghani M, Schofer J and Soliman O (2018) Transcatheter Interventions for Tricuspid Regurgitation: Rationale, Overview of Current Technologies, and Future Perspectives Practical Manual of Tricuspid Valve Diseases, 10.1007/978-3-319-58229-0_18, (353-377), . Girdauskas E, Lauer B and Kuntze T (2016) Transapical tricuspid valve‐in‐ring implantation: An alternative approach to a challenging clinical scenario, Catheterization and Cardiovascular Interventions, 10.1002/ccd.26695, 91:5, (1005-1008), Online publication date: 1-Apr-2018. Kuwata S, Nietlispach F, Maisano F and Taramasso M (2018) Interventions in Structural Heart Diseases: Tricuspid Valve Regurgitation Textbook of Catheter-Based Cardiovascular Interventions, 10.1007/978-3-319-55994-0_104, (1789-1806), . Revuelta J and Pomar J (2018) La sustitución protésica de la válvula tricúspide: de Cenicienta a Princesa, Cirugía Cardiovascular, 10.1016/j.circv.2018.05.001, 25:4, (175-177), Online publication date: 1-Jul-2018. Aboulhosn J, Cabalka A, Levi D, Himbert D, Testa L, Latib A, Makkar R, Boudjemline Y, Kim D, Kefer J, Bleiziffer S, Kerst G, Dvir D and McElhinney D (2017) Transcatheter Valve-in-Ring Implantation for the Treatment of Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair, JACC: Cardiovascular Interventions, 10.1016/j.jcin.2016.10.036, 10:1, (53-63), Online publication date: 1-Jan-2017. Campelo-Parada F, Lairez O and Carrié D (2017) Percutaneous Treatment of the Tricuspid Valve Disease: New Hope for the "Forgotten" Valve, Revista Española de Cardiología (English Edition), 10.1016/j.rec.2017.05.010, 70:10, (856-866), Online publication date: 1-Oct-2017. Campelo-Parada F, Lairez O and Carrié D (2017) Tratamientos percutáneos de la valvulopatía tricuspídea: una nueva esperanza para la válvula «olvidada», Revista Española de Cardiología, 10.1016/j.recesp.2017.04.020, 70:10, (856-866), Online publication date: 1-Oct-2017. Al-Hijji M, Fender E, El Sabbagh A and Holmes D (2017) Current Treatment Strategies for Tricuspid Regurgitation, Current Cardiology Reports, 10.1007/s11886-017-0920-4, 19:11, Online publication date: 1-Nov-2017. Fender E, Nishimura R and Holmes D (2016) Percutaneous therapies for tricuspid regurgitation, Expert Review of Medical Devices, 10.1080/17434440.2017.1268912, 14:1, (37-48), Online publication date: 2-Jan-2017. Scarsini R, Lunardi M, Pesarini G, Castriota F, Feola M, Ferrero V, Faggian G, Vassanelli C and Ribichini F (2017) Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon–expandable aortic valves, International Journal of Cardiology, 10.1016/j.ijcard.2017.02.076, 235, (141-146), Online publication date: 1-May-2017. Bouleti C, Juliard J, Himbert D, Iung B, Brochet E, Urena M, Dilly M, Ou P, Nataf P and Vahanian A (2016) Tricuspid valve and percutaneous approach: No longer the forgotten valve!, Archives of Cardiovascular Diseases, 10.1016/j.acvd.2015.08.002, 109:1, (55-66), Online publication date: 1-Jan-2016. Praz F, Windecker S, Huber C, Carrel T and Wenaweser P (2015) Expanding Indications of Transcatheter Heart Valve Interventions, JACC: Cardiovascular Interventions, 10.1016/j.jcin.2015.08.015, 8:14, (1777-1796), Online publication date: 1-Dec-2015. Campelo-Parada F, Perlman G, Philippon F, Ye J, Thompson C, Bédard E, Abdul-Jawad Altisent O, Del Trigo M, Leipsic J, Blanke P, Dvir D, Puri R, Webb J and Rodés-Cabau J (2015) First-in-Man Experience of a Novel Transcatheter Repair System for Treating Severe Tricuspid Regurgitation, Journal of the American College of Cardiology, 10.1016/j.jacc.2015.09.068, 66:22, (2475-2483), Online publication date: 1-Dec-2015. Taramasso M, Pozzoli A, Guidotti A, Nietlispach F, Inderbitzin D, Benussi S, Alfieri O and Maisano F (2016) Percutaneous tricuspid valve therapies: the new frontier, European Heart Journal, 10.1093/eurheartj/ehv766, (ehv766) March 2015Vol 8, Issue 3 Advertisement Article InformationMetrics © 2015 American Heart Association, Inc.https://doi.org/10.1161/CIRCINTERVENTIONS.114.002225PMID: 25744764 Manuscript receivedNovember 25, 2014Manuscript acceptedFebruary 17, 2015Originally publishedMarch 5, 2015 Keywordstranscatheter aortic valve implantationtricuspid valvePDF download Advertisement SubjectsCatheter-Based Coronary and Valvular Interventions
Referência(s)